Want a sense of security from your investment portfolio? “Comfort stocks” in those companies with less reliance on the shaky global economy for their prosperity and that get the majority of their revenues and profits from within the United States. This kind of “Sold in the USA” portfolio has outpaced the S&P 500 in recent years. For more detailed analysis, check out Alpha Now’s “Idea of the Week” below:
Walt Disney Co posted strong Q2 2012 earnings, rising 31% for the quarter. The company attributed its success to excellent box office sales of its movie “The Avengers” as well as improved revenue from its theme parks. If Disney can continue to outperform, its shareholders will benefit. Here are Disney’s top 10 active institutional investors.
Drugmakers Pfizer Inc (PFE-N) and Johnson & Johnson (JNJ-N) decided to end further studies of a closely watched drug, bapineuzumab, aimed to treat Alzheimer’s disease after the treatment failed in a second late-stage clinical trial.
Both companies will discontinue all remaining studies of the drug, including two more late-stage trials and follow-up extension studies, in patients with mild to moderate Alzheimer’s. The drug is designed to prevent the build-up of amyloid plaque in the brain. Both companies stated that the intravenous bapineuzumab therapy failed to improve cognitive and functional performance compared with placebo in patients who had mild to moderate Alzheimer’s.
As a result, the losses incurred by both companies will have a detrimental effect on third quarter earnings. See the report outlining which shareholders may be most affected. Check out other reports by Thomson Reuters Ownership Intelligence and follow @ownershipintel on Twitter.
Best Buy’s founder, Richard Schulze, has offered to take the company private. Mr. Schulze has offered $24-$26 per share and has talked with the former CEO and COO about coming back. Any buyout should be a boon for Best Buy’s current investors. Here are the top 10 active institutional shareholders who would stand to benefit. Check out other reports by Thomson Reuters Ownership Intelligence and follow @ownershipintel on Twitter.
General Motors Corp posted better earnings than expected for Q2 2012.
Two main factors driving its success were unusually good results in Europe and delayed spending in the United States. Some analysts are concerned that GM’s excellent quarter may be an anomaly. In particular, the delayed spending must be made up in the future, which could affect the bottom line. Also, as volatility in Europe continues, there is no guarantee GM’s European business will post another successful quarter. If the outlook on GM declines, GM’s top 10 shareholders could be affected.
Analysts are typically optimistic when it comes to the stocks they cover but Starmine takes that into account when it calculates intrinsic value, basically a real value for stocks like Salesforce. Here are Starmine’s most overrated and underrated tech stocks.
Watch more Investing 201 episodes.
Apple Inc missed analysts’ expectations for Q2 2012. The California-based technology company attributed the poor results to lagging iPhone sales ahead of the iPhone 5 rollout later this year, as well as poor sales in Europe. The list below shows the top 10 active institutional shareholders of Apple Inc. Check out other reports by Thomson Reuters Ownership Intelligence and follow @ownershipintel on Twitter.